USClinicalTrials.govClinical trialPhase 1Not yet recruiting
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
Official record
- Identifier
NCT05038098- Recruiting locations
country
United States- Interventions studied
- GastrectomyIndocyanine GreenIron Conjugated Polymers in Saline Suspension
- Lead sponsor
- M.D. Anderson Cancer Center
- Target enrolment
- 20 participants
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Status
- Not yet recruiting
- First posted
- Sep 8, 2021
- Last updated on the registry
- Aug 14, 2026
- Age
- 18 Years
- Sex
- ALL
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Age 18 or older * Willing to provide informed consent * Biopsy proven gastric cancer, undergoing curative-intent gastrectomy * No distant metastases * Pathologic diagnosis of gastric adenocarcinoma * Pre-treatment endoscopic measurement of less than or equal to 4 cm in diameter of the gastric cancer Exclusion Criteria: * Contraindications to surgery +/- adjuvant therapy * Allergy or intolerance to iron oxide compounds * Allergy or intolerance to iodides * Iron overload disorder * Pregnant or lactating women\* * Use of contraception is required for females during the study. Male patients who are sexually active with a female of childbearing potential are allowed for study enrollment and will not require use of contraception
- Indexed under
- Gastric Cancer